Detalhe da pesquisa
1.
Molecular subtypes of lung adenocarcinoma present distinct immune tumor microenvironments.
Cancer Sci
; 2024 Mar 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-38527308
2.
The molecular rationale for the combination of polatuzumab vedotin plus rituximab in diffuse large B-cell lymphoma.
Br J Haematol
; 199(2): 245-255, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35764309
3.
Neutrophil-to-lymphocyte ratio is a prognostic factor reflecting immune condition of tumor microenvironment in squamous cell lung cancer.
Sci Rep
; 14(1): 429, 2024 01 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-38172491
4.
Rapid in vitro assessment of the immunogenicity potential of engineered antibody therapeutics through detection of CD4+ T cell interleukin-2 secretion.
MAbs
; 15(1): 2253570, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37682072
5.
Tumor-infiltrating Leukocyte Profiling Defines Three Immune Subtypes of NSCLC with Distinct Signaling Pathways and Genetic Alterations.
Cancer Res Commun
; 3(6): 1026-1040, 2023 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-37377611
6.
Combination of T cell-redirecting bispecific antibody ERY974 and chemotherapy reciprocally enhances efficacy against non-inflamed tumours.
Nat Commun
; 13(1): 5265, 2022 09 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-36071036
7.
Whole genome assembly of a natto production strain Bacillus subtilis natto from very short read data.
BMC Genomics
; 11: 243, 2010 Apr 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-20398357
8.
An anti-glypican 3/CD3 bispecific T cell-redirecting antibody for treatment of solid tumors.
Sci Transl Med
; 9(410)2017 Oct 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-28978751